European patient survey on CAR T-cell therapy to gain insights into patients’ experiences, quality of life and unmet needs

by Danny Liu | Jan 27, 2023 | Uncategorized

Also available in: Deutsch Français Español Nederlands Italiano Português After months of preparation and close collaboration with patient advocacy groups, patients and carers, the T2EVOLVE and QUALITOP consortia are proud to launch their European patient survey on...

Details about upcoming launch of the European Patient Survey on CAR T-cell therapy

by Danny Liu | Jan 12, 2023 | Uncategorized

Next week, the T2EVOLVE and QUALITOP consortia will launch a survey developed to understand, analyze and meet the needs of European patients treated with CAR-T therapy for hematological cancers. To reach and engage as many patients as possible, T2EVOLVE’s Work...

Happy holidays from everyone at T2EVOLVE

by Danny Liu | Dec 20, 2022 | Uncategorized

Join T2EVOLVE at the 5th European CAR T-cell meeting

by Danny Liu | Nov 22, 2022 | Uncategorized

The 5th European CAR T-cell Meeting takes place in Rotterdam, the Netherlands, on February 9-11, 2023. The meeting is the largest CAR-T event in Europe in 2023. The previous edition of the meeting had more than 1.000 on-site participants and 120 abstracts. For the...

Hélène Negre and Michael Hudecek to speak at Onco Cell Therapy Summit Europe

by Danny Liu | Oct 26, 2022 | Uncategorized

Hélène Negre, T2EVOLVE Project Leader, and Michael Hudecek, T2EVOLVE Project Coordinator, are speakers at the Onco Cell Therapy Summit Europe in Amsterdam on Thursday, November 3. Hélène will present the T2EVOLVE Consortium while Michael speaks about new targets and...